-
Company Insights
Catalyst Monitor: Q2 2026 Outlook
This report compiles published, predictive intelligence based on interviews with key opinion leaders (KOLs) on market-moving events that are expected to occur in Q2 2026. GlobalData’s latest report, “Catalyst Monitor Q2 2026”, delivers forward-looking intelligence derived from interviews with key opinion leaders (KOLs), covering trial initiations, completions, top-line results, regulatory filings, PDUFA dates, and expected approvals. The report covers 15 significant catalyst events that are expected to occur in Q2 2026. Some of the catalysts covered in the report, include...
-
Sector Analysis
Emerging Market Outsourcing Report, Q1 2026
This expert outsourcing report is a comprehensive look at the pharmaceutical manufacturing landscape for emerging markets in Q1 2026, including analysis of news and trends affecting contract manufacturing organizations (CMOs) and the identification of recent contract service agreements, mergers, acquisitions, and financing among CMOs. It is a critical source for strategic planning efforts and will improve understanding of crucial components of the pharmaceutical value chain that will provide insights into API (biologics and chemical) as well as dose manufacturing and...
-
Analyst Opinions
Ambient Agents: Market Trends and Innovations
Ambient agents are emerging as a new enterprise computing paradigm, where software operates continuously in the background to sense context, make decisions, and execute workflows without explicit user initiation. The Innovation Radar: Ambient Agents report examines how AI is evolving from prompt-driven assistants into persistent, context-aware systems that maintain workflow continuity and coordinate actions across increasingly complex, multi-system enterprise environments. At the core of this shift is a maturing ambient agent stack that integrates event-driven infrastructure with contextual reasoning and...
-
Sector Analysis
Bio/Pharmaceutical Outsourcing Report, February 2026
The Bio/Pharmaceutical Outsourcing Report is a monthly analysis of news and trends affecting pharmaceutical Contract Manufacturing Organizations (CMOs). It includes in-depth analyses of the latest business conditions, lists new outsourcing contracts, assesses the latest opportunities and threats for manufacturers, and identifies recent mergers, acquisitions, and financing among CMOs. It also updates readers on facility-level news, such as planned site openings and closures, Good Manufacturing Practice (GMP) inspections, and investments in technology and equipment.
-
Thematic Analysis
Precision and Personalized Medicine - Advanced Therapeutics: Strategic Intelligence
Understand the Future of Precision and Personalized Medicine (PPM) Precision and personalized medicine is reshaping how diseases are diagnosed, treated, and managed. This report helps you understand where the market is heading and how advanced therapeutics are evolving. You will gain insight into how gene-modified cell therapies, gene therapy, and other advanced modalities are influencing treatment outcomes. Moreover, the report highlights how healthcare is shifting from reactive care to proactive, targeted intervention. As a result, you can better assess where...
-
Sector Analysis
Bio/Pharmaceutical Outsourcing Report, January 2026
The Bio/Pharmaceutical Outsourcing Report is a monthly analysis of news and trends affecting pharmaceutical Contract Manufacturing Organizations (CMOs). It includes in-depth analyses of the latest business conditions, lists new outsourcing contracts, assesses the latest opportunities and threats for manufacturers, and identifies recent mergers, acquisitions, and financing among CMOs. It also updates readers on facility-level news, such as planned site openings and closures, Good Manufacturing Practice (GMP) inspections, and investments in technology and equipment.
-
Analyst Opinions
Biocomputing: Market Trends and Innovations
Biocomputing is transitioning from a research-led concept into a deployable computing paradigm, where computation is executed through molecular and cellular processes rather than electronic circuits. The latest Innovation Radar: Biocomputing report examines how biology is being engineered as a programmable execution layer, capable of storing information, processing logic, and generating outputs directly within biological environments. At the core of this shift is a maturing biocomputing stack that integrates biological substrates with digital infrastructure. Computation is encoded in DNA, RNA, proteins,...
-
Thematic Analysis
Energy Transition in Oil and Gas: Strategic Intelligence
Energy transition expectations collide with harsh realities. Despite recurring climate-related catastrophes and consistent calls for emission reductions, the pace of the global energy transition is faltering. According to the International Energy Agency (IEA), energy-related CO₂ emissions hit a record 37.8 gigatonnes in 2024, marking more than a six-fold increase since 1950 and reflecting the ongoing dominance of fossil fuels in the world’s energy mix. Major oil and gas companies continue to face public and regulatory pressure to embrace lower-carbon business...
-
Sector Analysis
Bio/Pharmaceutical Outsourcing Report, December 2025
The Bio/Pharmaceutical Outsourcing Report is a monthly analysis of news and trends affecting pharmaceutical Contract Manufacturing Organizations (CMOs). It includes in-depth analyses of the latest business conditions, lists new outsourcing contracts, assesses the latest opportunities and threats for manufacturers, and identifies recent mergers, acquisitions, and financing among CMOs. It also updates readers on facility-level news, such as planned site openings and closures, Good Manufacturing Practice (GMP) inspections, and investments in technology and equipment.
-
Sector Analysis
Bio/Pharmaceutical Outsourcing Report, November 2025
The Bio/Pharmaceutical Outsourcing Report is a monthly analysis of news and trends affecting pharmaceutical Contract Manufacturing Organizations (CMOs). It includes in-depth analyses of the latest business conditions, lists new outsourcing contracts, assesses the latest opportunities and threats for manufacturers, and identifies recent mergers, acquisitions, and financing among CMOs. It also updates readers on facility-level news, such as planned site openings and closures, Good Manufacturing Practice (GMP) inspections, and investments in technology and equipment.
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.